Stock Comparison
ARGX vs INSM
argenx NV ADR and Insmed Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$26.84B
P/E (TTM)
32.7
—
Forward P/E
30.4
15.4
Price/Sales
10.0
23.6
Price/Book
6.4
35.4
EV/EBITDA
27.6
-5.7
Dividend Yield
—
—
Profitability
Net Margin
30.44%
-144.44%
Operating Margin
27.34%
-137.74%
Return on Equity
23.60%
-87.20%
Return on Assets
11.60%
-22.20%
Growth (YoY)
Revenue Growth
59.30%
296.10%
Earnings Growth
95.20%
0.00%
Price & Risk
Beta
-0.0
0.8
52-Week High
$939.68
$211.41
52-Week Low
$652.43
$91.88
Analyst Target
$1,085.78
$197.82
Compare ARGX and INSM your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.